These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7800911)

  • 21. Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST).
    Cooper-DeHoff RM; Aranda JM; Gaxiola E; Cangiano JL; Garcia-Barreto D; Conti CR; Hewkin A; Pepine CJ;
    Am Heart J; 2006 May; 151(5):1072-9. PubMed ID: 16644338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Slow-release verapamil poisoning. Use of polyethylene glycol whole-bowel lavage and high-dose calcium.
    Buckley N; Dawson AH; Howarth D; Whyte IM
    Med J Aust; 1993 Feb; 158(3):202-4. PubMed ID: 8450791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe verapamil (sustained-release) overdose.
    Krick SE; Gums JG; Grauer K; Cooper GR
    DICP; 1990; 24(7-8):705-6. PubMed ID: 2375141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overdose of sustained release verapamil.
    Rankin RJ; Edwards IR
    N Z Med J; 1990 Apr; 103(887):165. PubMed ID: 2342687
    [No Abstract]   [Full Text] [Related]  

  • 25. Slow-release verapamil and hyperglycemic metabolic acidosis.
    Roth A; Miller HI; Belhassen B; Laniado S
    Ann Intern Med; 1989 Jan; 110(2):171-2. PubMed ID: 2909215
    [No Abstract]   [Full Text] [Related]  

  • 26. Population analyses of sustained-release verapamil in patients: effects of sex, race, and smoking.
    Kang D; Verotta D; Krecic-Shepard ME; Modi NB; Gupta SK; Schwartz JB
    Clin Pharmacol Ther; 2003 Jan; 73(1):31-40. PubMed ID: 12545141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical injury of the oral mucosa from verapamil.
    Guttenberg SA
    N Engl J Med; 1990 Aug; 323(9):615. PubMed ID: 2381453
    [No Abstract]   [Full Text] [Related]  

  • 28. [Evaluation of the antihypertensive efficacy and safety of using sustained release verapamil in elderly subjects using ambulatory blood pressure monitoring].
    Jasiński T; Janicki K; Klima M; Pieniazek W; Bednarz S
    Przegl Lek; 1996; 53(2):73-7. PubMed ID: 8754325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-acting verapamil and heart failure.
    Mohindra SK; Udeani GO
    JAMA; 1989 Feb; 261(7):994. PubMed ID: 2915424
    [No Abstract]   [Full Text] [Related]  

  • 30. Disturbing dreams with long-acting verapamil.
    Kumar KL; Hodges M
    N Engl J Med; 1988 Apr; 318(14):929-30. PubMed ID: 3352680
    [No Abstract]   [Full Text] [Related]  

  • 31. Case report: fatal overdose with sustained-release verapamil.
    MacDonald D; Alguire PC
    Am J Med Sci; 1992 Feb; 303(2):115-7. PubMed ID: 1539608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of isoptin SR-240 in treatment of hypertension].
    Knypl K; Brym E; Wacławek-Maczkowska J
    Wiad Lek; 1993 Dec; 46(23-24):898-901. PubMed ID: 7900385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case report: sustained-release verapamil overdose causing stroke: an unusual complication.
    Shah AR; Passalacqua BR
    Am J Med Sci; 1992 Dec; 304(6):357-9. PubMed ID: 1456274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The bioavailability of a slow-release verapamil formulation.
    Norris RJ; Muirhead DC; Christie RB; Devane JG; Bottini PB
    Br J Clin Pract Suppl; 1985 Jun; 42():9-16. PubMed ID: 3929828
    [No Abstract]   [Full Text] [Related]  

  • 35. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamics of controlled release verapamil in patients with hypertension: an analysis using spline functions.
    Aarons L; Baxter C; Gupta S
    Biopharm Drug Dispos; 2004 Jul; 25(5):219-25. PubMed ID: 15248191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
    Widimský J; Dzúrik R
    Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A new approach to the evaluation of the effectiveness of antihypertensive therapy in patients with mild and moderate arterial hypertension based on the example of isoptin retard].
    Arabidze GG; Dmitriev VV; Rogoza AN
    Klin Med (Mosk); 1994; 72(5):27-30. PubMed ID: 7853810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained release verapamil workshop. Tarrytown, New York, 17 January 1985.
    Br J Clin Pract Suppl; 1985 Jun; 42():1-55. PubMed ID: 3929823
    [No Abstract]   [Full Text] [Related]  

  • 40. Hypertension in the elderly: 24 h ambulatory blood pressure results from a placebo-controlled trial.
    Neutel JM; Smith DH; Lefkowitz MP; Cargo P; Alemayehu D; Weber MA
    J Hum Hypertens; 1995 Sep; 9(9):723-7. PubMed ID: 8551485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.